Published in Arthritis Res Ther on June 14, 2012
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. J Transl Med (2014) 0.76
Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis. Arch Med Sci (2016) 0.75
B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis. Arthritis Res Ther (2016) 0.75
Blockade of PDGF receptors by crenolanib has therapeutic effect in patient fibroblasts and in preclinical models of systemic sclerosis. J Invest Dermatol (2017) 0.75
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1980) 21.86
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med (2006) 4.46
Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev (2004) 3.14
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford) (2009) 2.35
B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum (2009) 2.26
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J (2007) 1.78
B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol (2006) 1.64
Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev Cell (2009) 1.61
CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest (2002) 1.61
Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol (1999) 1.42
Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol (1995) 1.38
Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum (2009) 1.36
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis (2010) 1.34
Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol (1989) 1.28
CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol (2008) 1.23
Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol (1999) 1.12
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum (1990) 1.11
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial. Arthritis Res Ther (2010) 1.09
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis. Clin Exp Rheumatol (2012) 1.08
Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis. Pathol Int (2001) 1.05
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol (2004) 1.02
The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study. Dermatology (2008) 0.98
CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model. Arthritis Rheum (2008) 0.96
Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Mod Pathol (2003) 0.89
Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am J Pathol (1996) 0.89
Increased plasma levels of platelet-derived growth factor activity in patients with progressive systemic sclerosis. Proc Soc Exp Biol Med (1989) 0.88
Expression of platelet-derived growth factor B-chain and platelet-derived growth factor beta-receptor in fibroblasts of scleroderma. J Dermatol Sci (1998) 0.87
Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections. Am J Clin Pathol (2000) 0.84
Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med (2010) 2.35
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford) (2009) 2.35
Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature. Semin Arthritis Rheum (2012) 1.55
Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo (2007) 1.50
ACTH as first line treatment for acute gout in 181 hospitalized patients. Joint Bone Spine (2012) 1.43
Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum (2010) 1.35
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. BMC Cancer (2013) 1.32
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum (2009) 1.22
Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature. Semin Arthritis Rheum (2009) 1.21
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis. Expert Opin Investig Drugs (2008) 1.19
Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis (2007) 1.10
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis. Clin Exp Rheumatol (2012) 1.08
The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? Semin Arthritis Rheum (2011) 1.05
Evaluation of margin status in lumpectomy specimens and residual breast carcinoma. Breast J (2006) 0.99
TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res (2007) 0.98
Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Mod Pathol (2007) 0.97
Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Invest (2011) 0.94
Targeting CD40L: a promising therapeutic approach. Clin Diagn Lab Immunol (2004) 0.92
Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol (2013) 0.89
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol (2010) 0.89
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease. Rheumatol Int (2006) 0.88
Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin Immunol (2002) 0.87
T-lymphocyte subsets in peripheral blood and liver tissue of patients with chronic hepatitis B and C. In Vivo (2011) 0.87
Expression of CD44 protein in renal cell carcinomas: association with p53 expression. Urol Oncol (2002) 0.85
Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome. Neuropathology (2008) 0.84
Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome. Ann Hematol (2004) 0.84
Intestinal epithelial cell proliferation, apoptosis and expression of tight junction proteins in patients with obstructive jaundice. Eur J Clin Invest (2010) 0.83
Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma. J Surg Res (2009) 0.83
Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. Semin Arthritis Rheum (2008) 0.83
Liver pathology and cell proliferation after octreotide administration following partial hepatectomy in rats: an experimental study. Dig Dis Sci (2002) 0.82
B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence. Int J Rheumatol (2011) 0.82
Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival. In Vivo (2014) 0.81
Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study. Dig Dis Sci (2003) 0.81
Survival for 5 years after repeat liver resections and multimodality treatment for metastatic intestinal leiomyosarcoma: report of a case. Surg Today (2002) 0.81
Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis. Ann Hepatol (2013) 0.81
B cells tell scleroderma fibroblasts to produce collagen. Arthritis Res Ther (2013) 0.79
Bombesin and neurotensin exert antiproliferative effects on oval cells and augment the regenerative response of the cholestatic rat liver. Peptides (2010) 0.79
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 0.79
The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas. Anticancer Res (2002) 0.79
BCL-2 and BAX expression and cell proliferation, after partial hepatectomy with and without ischemia, on cholestatic liver in rats: an experimental study. J Surg Res (2003) 0.78
Apoptosis and myofibroblast expression in human glomerular disease: a possible link with transforming growth factor-beta-1. Nephron (2002) 0.78
Immunohistochemical expression of TGF-beta1, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study. Int J Gastrointest Cancer (2002) 0.78
Treatment with TNFα blockers induces phenotypical and functional aberrations in peripheral B cells. Clin Immunol (2011) 0.78
The prognostic value of frozen section preimplantation graft biopsy in the outcome of renal transplantation. Ren Fail (2010) 0.78
Tuberculosis of the parotid gland. Tuberk Toraks (2009) 0.77
Antiovarian antibodies in primary Sjogren's syndrome. Rheumatol Int (2007) 0.77
Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats. World J Gastrointest Pathophysiol (2011) 0.77
The effect of ischemia on the regeneration of the cholestatic liver. An experimental study. Hepatogastroenterology (2002) 0.76
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo. Rheumatol Int (2010) 0.75
Lyn deficiency in B cells from patients with systemic lupus erythematosus: comment on the article by Flores-Borja et al. Arthritis Rheum (2006) 0.75
Moraxella catarrhalis-induced septic arthritis of a prosthetic knee joint in a patient with rheumatoid arthritis treated with anakinra: comment on the article by Schiff et al. Arthritis Rheum (2005) 0.75
Bony ears. Arthritis Rheum (2008) 0.75
Multiple intrahepatic implantations of hepatocellular carcinoma following percutaneous ethanol injection (PEI) therapy. Liver Int (2006) 0.75
A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake. Clin Neuropharmacol (2004) 0.75
Open dumps in the Hellenic prefecture of Laconia: statistical analysis of characteristics and restoration prioritization on the basis of a field survey. Waste Manag Res (2007) 0.75
Arthritis accompanying ileal pouchitis or undifferentiated HLA B27-related spondyloarthropathy? Rheumatol Int (2005) 0.75
Hepatocellular carcinoma in hepatectomized patients: biologic and therapeutic implications. Anticancer Res (2005) 0.75
Expression of apoptosis-related proteins bcl-2 and bax along with transforming growth factor (TGF-beta1) in the kidney of patients with glomerulonephritides. Ren Fail (2004) 0.75
Intestinal Perforation in Renal Transplant Recipients: A Single Center Experience of 2123 Recipients. Exp Clin Transplant (2016) 0.75
Metastatic adenocarcinoma of parotid gland originating from the ampulla of vater: case report and review of the literature. J Gastrointest Cancer (2008) 0.75